Supplementary Figure S5 from Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047 | Synapse
September 10, 2025Open Access
Supplementary Figure S5 from Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047
Puntos clave
Biomarker analysis reveals key CD8 characteristics in the tumor microenvironment, and highlights immune response dynamics.
Important findings include detailed profiles of CD8 T cells in advancing melanoma, emphasizing immune interactions.
Assessment of CD8 characterization focuses on tumor microenvironments and provides insights into patient responses to treatment.
These results suggest potential pathways for enhancing immune therapies, pushing for further studies in advanced melanoma.